On January 1, 2020, a patent with a book value of $288,000 and a remaining useful life of fourteen years was reported on the December 31, 2019 post-closing trial balance. In 2020, a further $140,000 of research costs was incurred during the research phase. A lawsuit was also brought against a competitor company regarding the use of a patented process for which legal costs of $42,000 were spent. On September 1, 2020, the lawsuit was concluded successfully, and the courts upheld the patent as valid, so the competitor would not be able to continue using the patented process. The company year-end is December 31 and follows IFRS.

Required: What amount should be reported on the SFP at December 31, 2020, assuming straight-line amortization?